EEF1A2 and familial pancreatic carcinoma: It is worth to underline that with respect to 80% of pancreatic cancers, only 30%-60% of breast cancer showed overexpression of eEF1A2 [38], underlying the heterogeneity of eEF1A2 expression in breast cancers.